Biktarvy
Showing 1 - 25 of 72
HIV-1-infection Trial in Saint Louis (Biktarvy Tab)
Terminated
- HIV-1-infection
- Biktarvy Tab
-
Saint Louis, MissouriSouthampton Healthcare, Inc.
Jan 3, 2023
Human Immunodeficiency Virus Trial (BIKTARVY 50Mg-200Mg-25Mg Tablet)
Not yet recruiting
- Human Immunodeficiency Virus
- BIKTARVY 50Mg-200Mg-25Mg Tablet
- (no location specified)
Mar 31, 2022
Hiv Trial (Doravirine 100Mg Tab, Raltegravir 600Mg Tab, Biktarvy 50/200/25 Tab)
Not yet recruiting
- Hiv
- Doravirine 100Mg Tab
- +2 more
- (no location specified)
Dec 15, 2022
Human Immunodeficiency Virus Trial in Newark (Dolutegravir/Lamivudine)
Active, not recruiting
- Human Immunodeficiency Virus
-
Newark, New JerseySaint Michael's Medical Center
May 3, 2022
Bictegravir in the Elderly Living With HIV (BICEP)
Active, not recruiting
- HIV-1-infection
- Bictegravir/Emtricitabine/Tenofovir Alafenamide 50 MG-200 MG-25 MG Oral Tablet [BIKTARVY]
-
Buffalo, New YorkEvergreen Health
Oct 28, 2022
Healthy Volunteers Trial in Caen (receive dissolved form of BIKTARVY®, receive crushed form of BIKTARVY®, receive solid form of
Completed
- Healthy Volunteers
- receive dissolved form of BIKTARVY®
- +2 more
-
Caen, FranceCHU de Caen
Jul 27, 2021
Sexually Transmitted Diseases Trial in Atlanta (Doxycycline, Biktarvy)
Completed
- Sexually Transmitted Diseases
- Doxycycline
- Biktarvy
-
Atlanta, GeorgiaHope Clinic
Sep 20, 2022
Hiv, Transgenderism Trial in Toronto (Biktarvy 50/200/25 Tab, Estradiol Tablets)
Recruiting
- Hiv
- Transgenderism
- Biktarvy 50/200/25 Tab
- Estradiol Tablets
-
Toronto, Ontario, CanadaMaple Leaf Research
Dec 15, 2022
HIV, Renal Transplant Rejection Trial in New York (BIKTARVY 50Mg-200Mg-25Mg Tablet)
Recruiting
- HIV Infections
- Renal Transplant Rejection
- BIKTARVY 50Mg-200Mg-25Mg Tablet
-
New York, New YorkWeill Cornell Medicine
Aug 1, 2022
HIV-1-infection Trial in London (BIKTARVY 50Mg-200Mg-25Mg Tablet)
Not yet recruiting
- HIV-1-infection
- BIKTARVY 50Mg-200Mg-25Mg Tablet
-
London, United KingdomChelsea & Westminster Hospital NHS Foundation Trust
Jun 24, 2021
HIV, Obesity Trial in Greenville (Biktarvy, Symtuza)
Not yet recruiting
- HIV Infections
- Obesity
- Biktarvy
- Symtuza
-
Greenville, North CarolinaAdult Specialty Care Clinic-East Carolina University
Jul 14, 2022
HIV Infection, Adherence, Medication, Adherence, Treatment Trial in Boston (Next-generation Reader and ID-Cap System, Truvada
Recruiting
- HIV Infection
- +4 more
- Next-generation Reader and ID-Cap System
- +2 more
-
Boston, MassachusettsFenway Health
Dec 20, 2022
HIV Trial in Barcelona (Biktarvy 50 mg/200 mg/25 mg film-coated tablets)
Not yet recruiting
- HIV Infections
- Biktarvy 50 mg/200 mg/25 mg film-coated tablets
-
Barcelona, SpainHospital Clinic i Provincial Barcelona
Oct 26, 2022
HIV-1-infection Trial in Barcelona (Biktarvy)
Recruiting
- HIV-1-infection
- Biktarvy
-
Barcelona, SpainHospital Clínic de Barcelona
Dec 16, 2021
HIV I Infection Trial in Orlando (Dolutegravir / Lamivudine Pill, Bictegravir / Emtricitabine / Tenofovir Alafenamide Pill)
Active, not recruiting
- HIV I Infection
- Dolutegravir / Lamivudine Pill
- Bictegravir / Emtricitabine / Tenofovir Alafenamide Pill
-
Orlando, FloridaOrlando Immunology Center
Sep 20, 2022
HIV Trial in Spain (BIKTARVY 50Mg-200Mg-25Mg Tablet and Dovato , Dovato 50Mg-300Mg Tablet + Biktarvy )
Not yet recruiting
- HIV Infections
- BIKTARVY 50Mg-200Mg-25Mg Tablet and Dovato placebo
- Dovato 50Mg-300Mg Tablet + Biktarvy placebo
-
Palma De Mallorca, Islas Baleares, Spain
- +13 more
Oct 4, 2022
HIV-1-infection Trial in Edmonton (B/F/TAF, Atripla, B/F/TAF Placebo)
Terminated
- HIV-1-infection
- B/F/TAF
- +3 more
-
Edmonton, Alberta, CanadaUniversity of Alberta
Nov 21, 2022
HIV Trial in Boston (Biktarvy)
Active, not recruiting
- HIV
- Biktarvy
-
Boston, Massachusetts
- +2 more
Jun 7, 2021
HIV-1-infection Trial in Kisumu, Nairobi (Switch to B/F/TAF, Continue current regimen)
Active, not recruiting
- HIV-1-infection
- Switch to B/F/TAF
- Continue current regimen
-
Kisumu, Kenya
- +1 more
May 24, 2022
HIV Trial in Madrid (Bictegravir/Emtricitabine/Tenofovir Alafenamide 50 MG-200 MG-25 MG Oral Tablet [BIKTARVY])
Not yet recruiting
- HIV Infections
- Bictegravir/Emtricitabine/Tenofovir Alafenamide 50 MG-200 MG-25 MG Oral Tablet [BIKTARVY]
-
Madrid, SpainH. Infanta Leonor
Jun 2, 2022